Higher m7G scores seemed to be associated with inhibited immune status in cancer tissues, we wondered if the m7G modification level would affect the outcomes of the immunotherapy using the phase 3 clinical data of anti-PDL1 antibody Avelumab (NCT02684006) in advanced renal cell carcinoma (RCC) (Motzer et al., 2020). Here, CD274 is linked to cancer.